Oaktree Acquisition Corp. III Life Sciences’ (NASDAQ:OACCU – Get Free Report) quiet period is set to end on Tuesday, December 3rd. Oaktree Acquisition Corp. III Life Sciences had issued 17,500,000 shares in its initial public offering on October 24th. The total size of the offering was $175,000,000 based on an initial share price of $10.00. During Oaktree Acquisition Corp. III Life Sciences’ quiet period, underwriters and any insiders that worked on the IPO are restricted from issuing any research reports or earnings estimates for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company’s quiet period, it’s expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.
Oaktree Acquisition Corp. III Life Sciences Stock Down 1.0 %
NASDAQ OACCU opened at $10.12 on Tuesday. Oaktree Acquisition Corp. III Life Sciences has a 12 month low of $9.99 and a 12 month high of $10.22.
Featured Articles
- Five stocks we like better than Oaktree Acquisition Corp. III Life Sciences
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- Earnings Per Share Calculator: How to Calculate EPS
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- How to Invest in Biotech Stocks
- Discover the 3 Best Performing Stocks That Went Public in 2024
Receive News & Ratings for Oaktree Acquisition Corp. III Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oaktree Acquisition Corp. III Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
